ArticleExperimental and therapeutic medicine2023

The efficacy and safety of first‑line anti‑PD‑1/PD‑L1 immunotherapy for gastric esophageal cancer: A systematic review and meta‑analysis of phase III randomized controlled trials.

Xiaoyang Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.